Parabilis director granted 20,215 stock options
Parabilis Medicines, Inc. director Edward M. Fitzgerald received a grant of stock options covering 20,215 shares of common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Parabilis Medicines, Inc. director Edward M. Fitzgerald received a grant of stock options covering 20,215 shares of common stock. The options have an exercise price of $20.0000 per share and expire on June 8, 2036. The underlying 20,215 shares will vest and become exercisable in full on the earlier of June 9, 2027 or the date of the issuer's next annual meeting of stockholders, subject to his continued service on that vesting date.
Insider Trade Summary
Grant/Award: 20,215 shares
Grant/Award
1 txn
Insider
FITZGERALD EDWARD M
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 20,215 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 20,215 contracts (Direct)
Holdings Before and After:
Stock Option (Right to Buy), 0 to 20,215 contracts (Direct)
Footnotes (1)
- F1. The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) June 9, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.
Key Figures
Options granted: 20,215 options
Exercise price: $20.0000 per share
Underlying shares: 20,215 shares
+3 more
6 metrics
Options granted
20,215 options
Stock Option (Right to Buy) grant on June 9, 2026
Exercise price
$20.0000 per share
Exercise price for the 20,215 stock options
Underlying shares
20,215 shares
Common stock underlying the option grant
Post-grant derivative holdings
20,215 options
Total derivative securities following the transaction
Expiration date
June 8, 2036
Option expiration for the grant
Vesting date trigger
June 9, 2027 or next annual meeting
Earlier date when options vest, subject to continued service
Key Terms
Stock Option (Right to Buy), exercise price, vesting, expiration date, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 20.0000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares underlying this option shall vest and become exercisable in full"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-06-08T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
annual meeting of stockholders financial
"the Issuer's next annual meeting of stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Parabilis Medicines (PBLS) report for Edward M. Fitzgerald?
Parabilis Medicines reported that director Edward M. Fitzgerald received a grant of stock options for 20,215 shares. These options give him the right to buy common stock at a set price and represent a compensation-related award rather than an open-market share purchase.
What is the exercise price of Edward Fitzgerald’s Parabilis (PBLS) stock options?
The exercise price of Edward Fitzgerald’s Parabilis stock options is $20.0000 per share. This means he can purchase each underlying share at $20.0000 once the options vest and become exercisable, regardless of the market price at that future time.
When do Edward Fitzgerald’s Parabilis (PBLS) stock options vest and become exercisable?
The options vest and become exercisable in full on the earlier of June 9, 2027 or the date of Parabilis’ next annual stockholder meeting. Vesting is conditional on Edward Fitzgerald’s continued service with the company through that vesting date.
When do Edward Fitzgerald’s Parabilis (PBLS) stock options expire?
The stock options granted to Edward Fitzgerald expire on June 8, 2036. After this expiration date, the options can no longer be exercised, even if they previously vested and were otherwise exercisable under the terms of the grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
